Chemical Industry

Manufacturing expansions round-up

Manufacturing expansions round-up

By Natalie Morrison

in-PharmaTechnologist brings you a round-up of the latest new facilities and expansions for drugsmakers, including added cytotoxic capabilities for BTL, Jubilant’s launch of a special economic zone in India and plans for a $20m API plant for Omkar.

DSM's cost cuts pay off

DSM's cost cuts pay off

By Gregory Roumeliotis

Chemicals and nutrition group DSM has reported strong profits for
the first quarter in 2006, including in its pharma business, as
higher prices and lower costs have helped it overcome the increase
in raw material costs.


Follow us


View more


Featured Suppliers